false
--12-31
0001826011
0001826011
2025-12-17
2025-12-17
0001826011
BNZI:ClassCommonStockParValue0.0001PerShareMember
2025-12-17
2025-12-17
0001826011
BNZI:RedeemableWarrantsEachWholeWarrantExercisableForOneShareOfClassCommonStockAtExercisePriceOf11.50Member
2025-12-17
2025-12-17
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(D)
OF
THE SECURITIES EXCHANGE ACT OF 1934
Date
of Report (Date of earliest event reported): December 17, 2025
Banzai
International, Inc.
(Exact
name of registrant as specified in its charter)
| Delaware |
|
001-39826 |
|
85-3118980 |
(State
or other jurisdiction
of
incorporation) |
|
(Commission
File
Number) |
|
(I.R.S.
Employer
Identification
No.) |
435
Ericksen Ave, Suite 250
Bainbridge
Island, Washington |
|
98110 |
| (Address
of Principal Executive Offices) |
|
(Zip
Code) |
Registrant’s
telephone number, including area code: (206) 414-1777
(Former
name or former address, if changed since last report)
Check
the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under
any of the following provisions:
| ☐ |
Written
communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
|
| ☐ |
Soliciting
material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
|
| ☐ |
Pre-commencement
communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities
registered pursuant to Section 12(b) of the Act:
| Title
of each class |
|
Trading
Symbol(s) |
|
Name
of each exchange on which registered |
| Class
A common stock, par value $0.0001 per share |
|
BNZI |
|
The
Nasdaq Capital Market |
| |
|
|
|
|
| Redeemable
Warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 |
|
BNZIW |
|
The
Nasdaq Capital Market |
Indicate
by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405
of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging
growth company ☒
If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
Item
1.01. Entry Into a Material Definitive Agreement.
On
December 16, 2025, Banzai International, Inc., a Delaware corporation (the “Company”), entered into that certain Exchange
Agreement (the “Exchange Agreement”), dated as of December 15, 2025, (the “Effective Date”), by
and among Agile Capital Funding, LLC, a New York limited liability company (“Collateral Agent”) and Agile Lending,
LLC, a Virginia limited liability company (“Agile” or “Holder”), on the one hand, and the Company,
on the other hand (the “Exchange”). Pursuant to the Exchange Agreement, the Company shall exchange 232,786 shares
(the “Exchange Shares”) of its Class A common stock, par value $0.0001 per share (the “Common Stock”),
having an aggregate value of $284,000 (the “Note Exchange Amount”), valued at $1.22 per share, in exchange for
a reduction in an equivalent amount to the Note Exchange Amount to that certain Subordinated Secured Promissory Note to Agile in the
original principal amount of $4,000,000 (the “Note”), with a balance of $1,495,375.00 as of December 11, 2025 (the
“Note Balance”). In connection with the Exchange, the Company also entered into that certain Forbearance Agreement
(“Forbearance Agreement,” together with the Exchange Agreement, the “Transaction Documents”), dated
as of December 15, 2025, by and among the Company, Agile and Collateral Agent, pursuant to which Agile has agreed to forbear from exercising
its remedies with respect to certain events that would be considered Events of Default under the Note, and to temporarily modify certain
terms of the related loan agreement (the “Forbearance”), as of the closing date of the Exchange and the earlier of
(i) March 30, 2026, and (ii) the date of any Forbearance Default, as defined in the Forbearance Agreement (the “Forbearance
Period”).
As
partial consideration for the Collateral Agent’s and Agile’s agreement for the Forbearance, the Company shall pay to Agile a forbearance
fee of $628,057.50, in the form of an increase in the principal due under the Note (the “Forbearance Fee”). The Forbearance Fee will cause the outstanding principal under the Note to be increased from the Note Balance
to $2,123,432.50 (the “New Note Balance”). If the Forbearance Agreement is terminated for any reason whatsoever, the
principal due under the Note shall be the New Note Balance, and the Forbearance Fee shall be deemed earned by Agile and paid accordingly.
The Company also agreed to pay all of Agile’s reasonable costs and expenses,
in an amount not to exceed $10,000.
Upon
an Event of Default, as defined in the Forbearance Agreement, among other things, the Forbearance Period shall immediately cease, and
Agile may commence foreclosure proceedings with respect to the collateral over which the Company granted Agile a security interest pursuant
to the terms of the Forbearance Agreement.
The
Transaction Documents contain customary representations and warranties and conditions regarding the Exchange and Forbearance.
The
foregoing descriptions of the Exchange Agreement and the Forbearance Agreement are not complete and are qualified in their entirety
by reference to the full text of such agreements, copies of which are filed herewith as Exhibit
10.1 and Exhibit 10.2, respectively, to this Current Report on Form 8-K and
are incorporated herein by reference.
This
Current Report on Form 8-K shall not constitute an offer to sell or the solicitation of an offer to buy the securities discussed herein,
nor shall there be any sale of such securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful
prior to registration or qualification under the securities laws of any such state or jurisdiction.
Item
2.03 Creation of a Direct Financial Obligation or an Off-Balance Sheet Arrangement.
The
information contained in Item 1.01 of this Current Report on Form 8-K is incorporated in this Item 2.03 by reference.
Item
3.02. Unregistered Sales of Equity Securities
The
information contained in Item 1.01 of this Current Report on Form 8-K is incorporated in this Item 3.02 by reference.
Item
5.03 Amendments to Articles of Incorporation or Bylaws.
On
December 11, 2025, the Board of Directors of Banzai International, Inc. (the “Company”), approved,
as permitted by the Bylaws, to amend the Company’s Third
Amended and Restated Bylaws (the “Bylaws”), to reduce quorum requirements for shareholder meetings (the “Quorum Requirement”).
As per the approval, following
the 2025 Annual Shareholder Meeting to be held on January 15, 2026, Section 3.5 of the Company’s Bylaws shall be amended such that
the presence, in person, by remote communication, if applicable, or by proxy duly authorized, of the holders of 33.3% of the voting power
of the then-outstanding shares of capital stock entitled to vote shall constitute a quorum for the transaction of business.
The
above description of the amendment to the Bylaws is qualified in its entirety by reference to the Fourth Amended and Restated Bylaws,
a copy of which is attached hereto as Exhibit 3.1.
Item
9.01 Financial Statements and Exhibits.
(d)
Exhibits.
| Exhibit
No. |
|
Description |
| 3.1 |
|
Fourth Amended and Restated Bylaws |
| 10.1 |
|
Exchange Agreement |
| 10.2 |
|
Forbearance Agreement |
| 104 |
|
Cover Page Interactive
Data File (embedded within the Inline XBRL document) |
SIGNATURE
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
Dated:
December 17, 2025
| |
BANZAI INTERNATIONAL, INC. |
| |
|
|
| |
By: |
/s/ Joseph
Davy |
| |
|
Joseph Davy |
| |
|
Chief Executive Officer |